Showing results (61-70 of 361) with videos related to

Sort By:
Pageof 37
International Journal of Geriatric Psychiatry|March 9, 2011
Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal ADLorena Rami, Cristina Solé-Padullés, Juan Fortea, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 26, 2025
Serum level changes of the synaptic marker beta-synuclein in Alzheimer's disease continuum and other dementiasLorenzo Barba, Giovanni Bellomo, Daniel Alcolea, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 16, 2022
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profilesConstance Delaby, Daniel Alcolea, Christophe Hirtz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2021
AMYQ: An index to standardize quantitative amyloid load across PET tracersJordi Pegueroles, Victor Montal, Alexandre Bejanin, et al.
Neurobiology of Aging|April 17, 2012
Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementiaOriol Dols-Icardo, Marc Suárez-Calvet, Isabel Hernández, et al.
Scientific Reports|June 1, 2017
C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer diseaseMaría-Salud García-Ayllón, Inmaculada Lopez-Font, Claudia P Boix, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 8, 2024
Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior DisorderJèssica Pardo, Victor Montal, Anna Campabadal, et al.
American Journal of Alzheimer'S Disease and Other Dementias|May 23, 2013
Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementiaSónia Costa, Marc Suárez-Calvet, Sofia Antón, et al.
Ebiomedicine|October 4, 2024
Insights into the use of biomarkers in clinical trials in Alzheimer's diseaseTharick A Pascoal, Cristiano S Aguzzoli, Firoza Z Lussier, et al.
Pageof 37